T-Knife Therapeutics
Phase 1T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer.
Founded
2018
Focus
BiologicsCell & Gene Therapy
About
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer.
Funding History
2Total raised: $176M
Series B$110MAndera PartnersJun 15, 2021
Series A$66MVersant VenturesJan 15, 2020
Company Info
TypePrivate
Founded2018
LocationBerlin, Germany
StagePhase 1
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile